10 likes | 141 Views
Predicting 5-Aminosalicylate Nephrotoxicity in patients with IBD (5ASA) International IBD Genetics Consortium Projects www.ibdresearch.co.uk/5asa. Recruitment targets: UK - 200 International - 100. Message from Tariq Ahmad
E N D
Predicting 5-Aminosalicylate Nephrotoxicity in patients with IBD (5ASA) International IBD Genetics Consortium Projects www.ibdresearch.co.uk/5asa Recruitment targets: UK - 200 International - 100 • Message from Tariq Ahmad • We really appreciate your continued enthusiasm and support for the 5-ASA study. Please note: • 5ASA recruitment ends in 6 months, therefore we urgently need to turn every site on the map red as soon as possible. • The first adjudication panel is on the 31st October 2012. • Any cases that you would like to discuss please email: tariq.ahmad1@nhs.netor call Claire 01392 406928 • Clinicians who previously reported 5ASA Nephrotoxicity cases via the MHRAYELLOW CARD system will be sent information and contact details about the 5ASA study. We hope this will capture new cases which will be referred to local PIs.. • The e-CRF database is now up an running. To obtain log on details please contact either Dr Kenji So, or Claire Bewshea (details below). Key: Red – Patient’s recruitedBlue – Notrecruited yet Dr Tariq Ahmad (CI). Email: tariq.ahmad1@nhs.net Claire Bewshea Project Manager. Tel.: 01392 406928 Email: claire.bewshea@nhs.net Dr Kenji So, Research Fellow and Co-investigator. E-mail: kenji.so@nhs.net(Mob.: 07760 449147)